rochelsiprimage
6 August 2020AmericasMuireann Bolger

Federal Circuit won’t revisit revived Illumina DNA test patents

The US Court of Appeals for the Federal Circuit will not revisit its ruling that saved the patent eligibility of two DNA test patents owned by biotechnology company Illumina, after the court rejected an en banc request from a subsidiary of Roche.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
12 August 2020   McDermott Will & Emery has strengthened its IP practice in Boston with the addition of Michael Siekman and Jenny Chen as partners.
Americas
17 August 2020   The US Court of Appeals for the Federal Circuit has thrown out a patent infringement lawsuit brought by two Illinois doctors against more than 300 hospitals.
Americas
8 January 2021   Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.

More on this story

Americas
12 August 2020   McDermott Will & Emery has strengthened its IP practice in Boston with the addition of Michael Siekman and Jenny Chen as partners.
Americas
17 August 2020   The US Court of Appeals for the Federal Circuit has thrown out a patent infringement lawsuit brought by two Illinois doctors against more than 300 hospitals.
Americas
8 January 2021   Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.

More on this story

Americas
12 August 2020   McDermott Will & Emery has strengthened its IP practice in Boston with the addition of Michael Siekman and Jenny Chen as partners.
Americas
17 August 2020   The US Court of Appeals for the Federal Circuit has thrown out a patent infringement lawsuit brought by two Illinois doctors against more than 300 hospitals.
Americas
8 January 2021   Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.